Visfo
Visfo is a UK-based healthtech consultancy and software provider that combines data science consulting with its proprietary HelixAI platform to deliver strategic intelligence, evidence development, and bespoke enterprise software to pharmaceutical, biotech, and consumer health companies worldwide.
- Company typePrivate
- Founded2018
- HeadquartersBrighouse, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Visfo does
Visfo is a UK-based healthtech consultancy and software provider that serves pharmaceutical, biotechnology, and consumer health companies with strategic intelligence, data science, and software solutions. The firm was founded by Dr. Max Noble (CEO) and operates from West Yorkshire, England, with clients worldwide across the US and European markets. Its positioning is built on combining cross-functional consulting expertise — spanning market access, R&D, medical affairs, evidence development, and commercial strategy — with a proprietary software platform, addressing the market need for healthcare teams to act on fragmented clinical, scientific, competitive, and digital data.
The company's core product is HelixAI, a collaborative delivery system that structures projects from scoping through solution with built-in communication, self-serve analytics, AI-powered summarization of dense scientific publications, custom alerts, and integrated insight feeds. HelixAI is fed by four data landscapes — Clinical (claims data, EHRs, trial site metrics), Scientific (literature mapping, author disambiguation, topic modeling), Competitive (trial design, pipelines, pricing, HTA decisions) and Digital (social media, forums, DOL tracking, sentiment analysis) — combined with NLP, machine learning, and statistical modeling. These data modules power bespoke Intelligence Boards and dashboards developed during consulting engagements and matured into enterprise software.
Visfo makes money through a hybrid model: short-duration, high-impact data-science consulting engagements (professional services) that typically convert into multi-year, customized SaaS subscriptions on HelixAI and bespoke enterprise software. Pricing is quote-based and not publicly disclosed. The company sells exclusively through direct enterprise field sales — no resellers, marketplaces, or self-service distribution — and its solution initiation flow is supported by a Solutions Builder tool on its website. Named clients include Pfizer, AbbVie, Bayer, Gilead, Janssen, Takeda, Allergan, Sumitomo, and Reckitt, with documented partnerships including the University of York and Oncology Access Solutions.
Visfo firmographics
Firmographics- Name
- Visfo
- Legal name
- VISFO
- Website
- https://visfo.health
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Visfo is a UK-based healthtech consultancy and software provider that combines data science consulting with its proprietary HelixAI platform to deliver strategic intelligence, evidence development, and bespoke enterprise software to pharmaceutical, biotech, and consumer health companies worldwide.
- Ownership category
- akta.pro rank
Visfo industry classification
Industry- Product category
- Pharmaceutical Intelligence Software
- NAICS
- Management Consulting Services (54161), Other Management Consulting Services (541618), Computer Systems Design and Related Services (5415), Computer Systems Design and Related Services (54151), Marketing Consulting Services (541613)
- SIC
- Services-Management Consulting Services (8742), Services-Computer Programming Services (7371), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Business Intelligence, Reporting & Visualization Services (BPAEAHAD)
- akta.pro secondary industries
- PV Regulatory Submissions & Safety Reporting (E2B/CIOMS/Expedited) (HLAGALAJ), Strategy & Corporate Development Consulting (BPAHACAA)
Keywords
Where Visfo is headquartered
LocationHeadquarters
- HQ city
- Brighouse
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Visfo business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Strategic Consulting Services: High-impact data science consulting engagements that solve immediate client challenges. Projects typically deliver working data science solutions in weeks, combining internal client data with Visfo's external data landscape and domain expertise across market access, R&D, medical affairs, and more.
- SaaS Software Platform (HelixAI): Software solutions delivered through their HelixAI platform, providing ongoing access to intelligence tools, dashboards, and AI-powered features. Solutions scale from rapid prototypes to full enterprise software tailored to client business needs.
- Software Development and Customization: Custom software development services that transform consulting solutions into scalable enterprise platforms. Development and deployment of enterprise-ready software tailored to client business, eliminating repeat work and embedding long-term strategic advantage.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom enterprise engagement - pricing based on project scope and complexity |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
Visfo product offering
Product offeringCore offering
Visfo is a UK-based life sciences strategic intelligence company that combines consulting engagements with a proprietary SaaS platform to help pharmaceutical, biotech, and consumer health organizations solve complex data challenges. The company delivers high-impact data science consulting projects spanning market access, R&D, medical affairs, and commercial decision support, alongside its HelixAI delivery platform that structures projects from scoping to solution with AI-powered summarization, self-serve analytics, and integrated insight feeds. Engagements typically begin as consulting projects and evolve into longer-term enterprise software relationships built on a comprehensive healthcare data landscape covering clinical, scientific, competitive, and digital domains.
Product overview
VISFO is a life sciences strategic intelligence company that combines SaaS consulting services with a proprietary software platform. Its core product is HelixAI, an AI-enhanced delivery system that structures data science projects from scoping through solution, providing self-serve analytics, AI-powered publication summarization, custom alerts, and integrated insight feeds. Complementing HelixAI are four data landscape modules — Clinical, Scientific, Competitive, and Digital — covering claims data, literature mapping, competitive pipelines, and social/digital signals. These data modules feed into tailored interactive Intelligence Boards and Dashboards developed during consulting engagements. The company pairs consulting engagements with rapid software prototyping, maturing validated solutions into enterprise-grade custom software.
Differentiator
Problem solved
Functional benefit
Products and services
- HelixAI
Quantifiable outcome
- Initial delivery in 4 weeks for FDA approval analysis case
- +2 more outcomes
Companies that use Visfo
Customer profileNamed customers12 records
Segments3 records
Ideal customer profiles3 records
Visfo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature5 records
Visfo partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and secondary.
- University of YorkcorePartnership includes the Enigma scholarship programme for undergraduate students from widening participation backgrounds. The collaboration also involves research partnerships with PhD students working within Haematology Malignancy Diagnostic Services at St James's University Hospital. Visfo's founder established the scholarship programme to widen participation in the healthcare technology sector.
- Oncology Access SolutionscoreCollaboration to author a publication on critical success factors for developing CAR T-cell therapies for cancer. The partnership focuses on planning the road ahead for CAR-T development and creating a modified approach to developing Target Product Profiles (TPP). Both companies contribute expertise in oncology market access and strategic intelligence.
- TakedasecondaryTakeda appears as a client logo on Visfo's website, indicating an active client relationship in the pharmaceutical sector.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Visfo competitors and assessment
Company assessmentDirect peers
- Axtria: Data analytics and AI platform company serving pharma with commercial operations, real-world evidence, and customer engagement solutions - directly comparable to VISFO's data science + software stack for life sciences.
- Trinity Life Sciences: US-based strategic consulting and analytics firm serving pharma and biotech with commercial strategy, competitive intelligence, and evidence generation - very similar offering to VISFO's consulting-plus-platform model.
- Eularis: Specialist pharma strategic analytics firm using AI and data science to support commercial strategy, market access, and launch decisions across pharma clients - very close fit to VISFO's consulting model.
- Evaluate (Norstella): Provides commercial intelligence and forecasting for pharma, including pipeline, pricing, and market access data. Comparable to VISFO's competitive landscape and market access offerings.
- Health Advances: Healthcare strategy consulting firm supporting pharma, biotech, and medtech with commercial strategy, market access, and opportunity assessments. Comparable consulting services to VISFO's strategic intelligence practice.
- Definitive Healthcare: Provider of healthcare commercial intelligence, analytics, and SaaS to life sciences companies. Overlaps with VISFO's clinical/competitive intelligence and data landscape products.
- ZS Associates: Global consulting and technology firm helping pharma companies with sales, marketing, and analytics strategies. Their AI/data capabilities and pharma focus mirror VISFO's strategic intelligence and SaaS delivery model.
Broad incumbents
- GlobalData Healthcare: Provides pharma market intelligence, clinical trial data, and industry analytics across multiple therapeutic areas. Comparable to VISFO's competitive and scientific landscape offerings.
- Informa Pharma Intelligence (Citeline): Provides pharma intelligence, clinical trial data, and drug development analytics. Their analytics products and competitive intelligence databases directly compete with VISFO's clinical and competitive data landscape modules.
- IQVIA: Global leader in life sciences analytics, R&D services, and commercial intelligence. Overlaps with VISFO's pharma intelligence, market access, and consulting offerings, but as part of a much broader portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Visfo social profiles
Digital presenceVisfo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Visfo leadership team
Management profileNumber of profiles
Profiles10 records
Visfo funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Visfo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Visfo
What does Visfo do?
Visfo is a UK-based life sciences strategic intelligence company that combines consulting engagements with a proprietary SaaS platform to help pharmaceutical, biotech, and consumer health organizations solve complex data challenges. The company delivers high-impact data science consulting projects spanning market access, R&D, medical affairs, and commercial decision support, alongside its HelixAI delivery platform that structures projects from scoping to solution with AI-powered summarization, self-serve analytics, and integrated insight feeds. Engagements typically begin as consulting projects and evolve into longer-term enterprise software relationships built on a comprehensive healthcare data landscape covering clinical, scientific, competitive, and digital domains.
Is Visfo a public or private company?
Visfo is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Visfo founded?
Visfo was founded in 2018. It employs 51 to 100 people.
Where is Visfo based?
Visfo is headquartered in Brighouse, United Kingdom, in the Europe region.
How does Visfo make money?
Three revenue lines are on record. Strategic Consulting Services are the primary driver. The others are saaS Software Platform (HelixAI) and software Development and Customization.
Who are Visfo's main competitors?
Direct peers on record are Axtria, Trinity Life Sciences, Eularis, Evaluate (Norstella), Health Advances, Definitive Healthcare and ZS Associates. Broad incumbents are GlobalData Healthcare, Informa Pharma Intelligence (Citeline) and IQVIA.
Does Visfo have an API?
No public API is recorded for Visfo.
What industry is Visfo in?
Visfo's product category is Pharmaceutical Intelligence Software. Its primary akta.pro industry code is BPAEAHAD, Business Intelligence, Reporting & Visualization Services, with a secondary code of HLAGALAJ, PV Regulatory Submissions & Safety Reporting (E2B/CIOMS/Expedited). Its NAICS code is 54161 and its SIC code is 8742.